Predictors of DAPSA28 Remission at 6 Months in Bio-Naive Patients with Psoriatic Arthritis Starting a TNF Inhibitor in Clinical Practice-Results from the EuroSpA Collaboration / Ornbjerg, Lm; Georgiadis, S; Jacobsson, L; Loft, Ag; Iannone, F; Moeller, B; Sexton, J; Mann, H; Santos, Mj; Pombo-Suarez, M; Eklund, Kk; Tomsic, M; Gudbjornsson, B; Erten, S; Codreanu, C; van der Horst-Bruinsma, I; Wallman, J; Sebastiani, M; Nissen, Mj; Kristianslund, E; Pavelka, K; Vieira-Sousa, E; Sanchez-Piedra, C; Trokovic, N; Rotar, Z; Love, Tj; Yolbas, S; Ionescu, R; van de Sande, M; Jones, G; Michelsen, B; Ostergaard, M; Hetland, Ml. - In: ARTHRITIS & RHEUMATOLOGY. - ISSN 2326-5191. - 71:(2019).
Predictors of DAPSA28 Remission at 6 Months in Bio-Naive Patients with Psoriatic Arthritis Starting a TNF Inhibitor in Clinical Practice-Results from the EuroSpA Collaboration
Sebastiani, M;
2019
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
